University of Otago Research Sheds Light on ME/CFS Challenges in Aotearoa New Zealand
Recent findings from the University of Otago highlight the significant difficulties experienced by individuals living with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) across health, employment, and social support systems. The nationwide study, the first of its kind in New Zealand to leverage linked population data, underscores the urgent need for improved understanding and services within the higher education and health sectors.
ME/CFS, a complex condition characterised by profound fatigue, post-exertional malaise, and a range of other symptoms that persist for more than six months, affects many New Zealanders. Researchers at the University of Otago – Ōtākou Whakaihu Waka examined outcomes for working-age people diagnosed with the condition, revealing patterns of high health service utilisation alongside limited access to tailored support.
Key Findings from the Population-Level Analysis
The study drew on Stats NZ’s Integrated Data Infrastructure to identify 1,902 individuals receiving health or disability-related benefits who had a recorded ME/CFS diagnosis. These participants were compared against other benefit recipients and the broader population. Results showed markedly elevated health needs, including greater emergency department visits and substantially higher medication use, with nearly one in three dispensed ten or more medications annually—more than double the general population rate.
Employment outcomes were particularly stark. Only 18 percent of those with ME/CFS were in paid work, compared with over 80 percent of the general population. Long-term reliance on income support was common, with nearly two-thirds receiving the Supported Living Payment and almost half continuously on benefits for five years or more.
Barriers to Disability Support and Systemic Gaps
Access to intensive disability services remained extremely limited, with just 1.6 percent of the ME/CFS group utilising these supports—far below the 7.2 percent rate among other benefit recipients. This discrepancy points to eligibility criteria that may not adequately accommodate fluctuating, invisible conditions like ME/CFS.
Co-author Fiona Charlton, president of the Associated New Zealand ME Society, noted that current systems are not well suited to chronic, variable illnesses, leaving many individuals unsupported despite clear need.
Equity Concerns and Under-Recognition Across Communities
The identified ME/CFS population was predominantly European, with Māori and other ethnic groups underrepresented. Researchers attribute this to barriers in diagnosis and service access rather than true prevalence differences, highlighting the need for culturally responsive approaches in healthcare and research.
Emeritus Professor Warren Tate emphasised the requirement for greater awareness throughout the health system, including education on research-based management strategies for ME/CFS and related conditions such as Long COVID.
Implications for Higher Education and Research Communities
University of Otago’s leadership in this area demonstrates the vital role of New Zealand’s tertiary institutions in addressing complex public health issues. The Department of Paediatrics and Child Health, alongside contributions from Pathology and Molecular Medicine, illustrates how interdisciplinary collaboration can generate actionable insights.
For academics, PhD candidates, and research administrators, the study signals opportunities in funding applications focused on chronic illness, data linkage methodologies, and equity-focused health research. Institutions may consider expanding curricula to include ME/CFS awareness in medical, nursing, and social work programmes.
Connections to Broader Chronic Illness Research at Otago
This hardship study builds on earlier University of Otago work exploring links between Long COVID and ME/CFS, reinforcing the institution’s position as a hub for advancing knowledge on post-viral and fatigue-related conditions. Such research supports evidence-based policy development at national levels.
Recommendations for Policy and Service Improvement
Lead author Dr Nick Bowden called for enhanced diagnostic pathways, better data collection, and person-centred care models that account for the long-term, fluctuating nature of ME/CFS. Integrated approaches across health, social services, and employment support could reduce economic hardship and improve quality of life.
Higher education providers are well placed to contribute through targeted research grants, student placements in chronic illness support organisations, and professional development for staff.
Future Outlook for ME/CFS Research in New Zealand
The findings provide a foundation for ongoing investigation into prevalence, effective interventions, and system reforms. Continued investment in university-led studies will be essential to making this population visible in policy and practice.
Readers interested in related academic opportunities can explore positions in health research and public policy through dedicated higher education job platforms.
Supporting Resources and Further Reading
Those seeking additional context on ME/CFS in New Zealand may consult official university announcements and society resources for the latest developments.